Wendan decoction in the treatment of nonalcoholic fatty liver disease: A systematic review and meta-analysis
Introduction: The use of Wendan decoction (WDD) as a therapy for nonalcoholic fatty liver disease (NAFLD) has been studied in many clinical trials, and some of them showed that WDD is effective for treating this condition. However, no comprehensive research to evaluate the clinical efficacy of WDD i...
Saved in:
Main Authors: | Yufeng Zhang (Author), Ting Liu (Author), Lianyue Zhang (Author), Zhongping Pu (Author), Zheng Yan (Author), Haibing Hua (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2022-10-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Network and Experimental Pharmacology to Decode the Action of Wendan Decoction Against Generalized Anxiety Disorder
by: Jin Q, et al.
Published: (2022) -
Activation of GABA type A receptor is involved in the anti-insomnia effect of Huanglian Wendan Decoction
by: Liang Li, et al.
Published: (2024) -
The relationship between folic acid and nonalcoholic fatty liver disease
by: Bing'er Xu, et al.
Published: (2024) -
Nonalcoholic Fatty Liver Disease An Update
Published: (2019) -
Semaglutide in the treatment of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis
by: Magdalena Mazurek, et al.
Published: (2023)